Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
François Mach, Frank L.J. Visseren, Nilo B. Cater, Néjoua Salhi, Jarkko Soronen, Kausik K. Ray, Victoria Delgado, J. Wouter Jukema, Ulrich Laufs, J. L. Zamorano, Emilio Ros, Jogchum Plat, Akos Gabor Gesztes, Lâle Tokgözoğlu, Chris J. Packard, Peter Libby
Topics & Concepts
MedicineResidual riskStatinIntensive care medicineDiabetes mellitusAtherosclerotic cardiovascular diseaseGuidelineDiseaseRisk assessmentPharmacotherapyCardiovascular eventInternal medicinePathologyEndocrinologyComputer scienceComputer securityLipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of LifeDiabetes, Cardiovascular Risks, and Lipoproteins